The Gorgas Courses in Clinical Tropical Medicine Selected Cases Seen by 2007 Course Participants |
| 2007
Case #7 Diagnosis & Discussion |
![]() |
|
| (Links to Other 2007 Cases are at bottom of this page) | ||
| Diagnosis: Mycetoma (madura foot syndrome) due to Phaeoacremonium inflatipes. |
Discussion: White draining granular material grew Phaeoacremonium inflatipes. Culture for bacteria was negative. Excisional biopsy or invasive cultures of the sinus tracts are not usually necessary for diagnosis of madura foot as the granules usually come to the surface even if not on a daily basis. The main and important differential diagnoses in this case are TB, botrymycosis (chronic staphylococcal infection) [see 2003 Case #4], actinomycosis [see 2001 Case #9], other causes of chronic bacterial osteomyelitis, and malignancy. Madura foot is a common subcutaneous mycosis in the tropics and is caused by a wide variety of fungal organism. Madura foot typically presents in a similar way to this patient, with a small local tumor slowly progressing over years to more widespread destruction of subcutaneous tissue and bone while sparing nerve and vasculature. Etiologic agents of maduramycosis are divided into several groups:
Mycetomas appear to be localized phenomena due to local inoculation without any potential for widespread dissemination. Maduramycosis is most common in Africa, Central and South America, and the Far East. Most cases occur in tropical latitudes between 15 degrees South and 30 degrees North in humid moist environments. The organisms have been isolated from soil as well as from plant thorns. The identification of species of Phaeoacremonium based on their morphological and cultural characters is difficult [see detailed review in J Clin Microbiol. 2005 Apr;43(4):1752-67], as is evident from the numerous incorrect identifications that have been made since the genus was established in 1996. A reliable technique for Phaeoacremonium species identification is needed. At present 6 species have been associated with human disease but reports in the literature are scanty.
Our patient has received itraconazole 200 mg/d for 1 year with some improvement [Image E]. |
9 Weeks Every February & March 2008 - Fully Enrolled; Waiting List Closed 2009 - Applications now being accepted |
Links to Selected Cases from 2007
Cases
will resume in February 2008 www.gorgas.org |
|||||